18F-Containing Positron Emission Tomography Probe Conjugation Methodology for Biologics as Specific Binders for Tumors

Author(s): Kenji Arimitsu, Hiroyuki Kimura, Yoshinari Arai, Kazuto Mochizuki, Masumi Taki

Journal Name: Current Topics in Medicinal Chemistry

Volume 16 , Issue 24 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Molecular imaging can be used to evaluate the spatial–time change of the molecular biological phenomenon of the cell–molecule level in living bodies. Molecular imaging technology is expected to be applied in the fields of drug development, clinical diagnosis, and life science research. Specifically, positron emission tomography (PET) is a powerful non-invasive imaging technology for investigating physiological parameters in living animals using compounds labeled with PET radioisotopes as molecular probes. This review summarizes and compares various 18F-conjugation techniques that employ the chemical and enzymatic reactions of different types of tumor-targeting biological molecules such as peptides, proteins, antibodies, and nucleic acids.

Keywords: Chemoenzymatic reaction, Chemical reaction, Positron emission tomography (PET) probe, Biologics, Biopharmaceutics, Fluorine-18 (18F), Peptide, Protein, Oligonucleotide, Antibody, Click chemistry, Tumor targeting.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 01 August, 2016
Page: [2703 - 2724]
Pages: 22
DOI: 10.2174/1568026616666160413125948
Price: $65

Article Metrics

PDF: 70
PRC: 2